Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
UTI Turns Out to Be Infective Endocarditis: An Unusual Presentation
9
Mins
May 2025
Infective endocarditis (IE) often presents in an unusual and vague manner, especially in its early stages, where symptoms can be…
Read more
20 Oct 2015
Treatment of Hypertension in New Frontiers
This symposium provided an excellent forum to discuss the global burden of hypertension, its challenges and approaches to best management.
20 Oct 2015
New Paradigms in Heart Failure: RAAS Inhibition and the Management of Hyperkalaemia
This educational symposium discussed advances in blocking the renin–angiotensin–aldosterone system (RAAS) for patients with chronic systolic heart failure..
20 Oct 2015
International, Large-Scale, Real-World Clinical Data Confirm the Safety Profile of Rivaroxaban
Rivaroxaban is a direct factor Xa inhibitor and a non-vitamin K antagonist (VKA) novel oral anticoagulant (NOAC) approved for a number of indications.
20 Oct 2015
Real-World Registry Study Confirms Fondaparinux Over Low-Molecular-Weight Heparin for NSTEMI
The pivotal Fifth Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS-5) trial demonstrated that fondaparinux was non-inferior to…
20 Oct 2015
Self-Expanding Coronary Stents: Rationale, Clinical Status, Future Prospects
The mechanical treatment of coronary artery stenoses by placement of balloon-expandable (Bx) coronary stents has become the most widely used invasive…
3 Mar 2015
Hypertension Care: It’s Time to Act
The satellite symposium was held in two separate sessions – the first a traditional symposium format, and the second as an interactive panel discussion in..
24 Feb 2015
Editor’s Pick: State of the Art of Aortic Valve Implantation: Indications, Outcomes, and Controversies
During the last decade, transcatheter aortic valve implantation (TAVI) has become a revolution in the treatment of high-risk severe aortic stenosis (AS).
24 Feb 2015
Cost-Effectiveness of a Novel Self-Apposing Stent in ST-Segment Elevation Myocardial Infarction (STEMI) in France
The objective was to calculate the cost-effectiveness profile of STENTYS compared to conventional bare and drug-eluting stents (DES).
Loading posts...
« Previous
1
…
18
19
20
21
22
…
24
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View